Business Context and Reporting Period
Company: Globus Medical, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 24, 2026
Reporting Period: The filing reports sales and operating results for the three and twelve-month periods ended December 31, 2025.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) for detailed financial data. The filing text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity.
- Revenue: Not specified in filing text.
- Profit: Not specified in filing text.
- Cash Flow: Not specified in filing text.
- Debt and Liquidity: Not specified in filing text.
Material Changes
The filing text does not contain specific data regarding material changes versus prior comparable periods. It only confirms that results for the periods ended December 31, 2025, were reported in the referenced press release.
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are contained within the press release furnished as Exhibit 99.1.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 24, 2026) for specific revenue, earnings, and cash flow figures.
- Verify year-over-year growth rates for the three and twelve-month periods ended December 31, 2025.
- Check the press release for any updated forward-looking guidance or strategic initiatives.
- Confirm the status of debt and liquidity positions as disclosed in the full press release.